New Pfizer Inc. Data in Lung Cancer, Ewing’s Sarcoma, Prostate Cancer and Other Difficult-to-Treat Tumor Types to Be Presented at American Society of Clinical Oncology

NEW YORK--(BUSINESS WIRE)--Pfizer announced today that study results across several difficult-to-treat cancers will be presented at the 44th American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3, 2008. Pfizer will hold two briefings for journalists on June 1 and investors on June 2.